Anti-inflammatory defense mechanisms of Entamoeba histolytica

被引:0
作者
Raúl Silva-García
Guadalupe Rico-Rosillo
机构
[1] CMN-Siglo XXI,Unidad de Investigación Médica en Inmunología, Hospital de Pediatría
[2] Av. Universidad 3000 circuito escolar s/n,División de Investigación, Facultad de Medicina UNAM
[3] Col. Copilco,undefined
来源
Inflammation Research | 2011年 / 60卷
关键词
In vivo inflammation; Wound healing; Leukocyte migration; Macrophages; NF-κB;
D O I
暂无
中图分类号
学科分类号
摘要
The monocyte locomotion inhibitory factor (MLIF), a heat-stable oligopeptide found in the supernatant fluid of Entamoeba histolytica axenic cultures, may contribute to the delayed inflammation observed in amoebic hepatic abscess. This factor was isolated by ultra-filtration and high powered liquid chromatography, obtaining a primary Met-Gln-Cys-Asn-Ser structure, identified afterwards as the carboxyl-terminal (…Cys-Asn-Ser) active site. The selective anti-inflammatory effects of the pentapeptide have been observed in both in vitro and in vivo models, using a synthetic pentapeptide to maintain the same anti-inflammatory conditions during the experimental assays. Anti-inflammatory effects observed include inhibition of human monocyte locomotion and the respiratory burst in monocytes and neutrophils, increasing expression of anti-inflammatory cytokines and inhibiting expression of the adhesion molecules VLA-4 and VCAM, among others. In this review, we will describe the effects of MLIF detected so far and how it might be used as a therapeutical agent against inflammatory diseases.
引用
收藏
页码:111 / 117
页数:6
相关论文
共 252 条
  • [1] Walsh JA(1986)Problems in recognition and diagnosis of amebiasis: estimation of the global magnitude of morbidity and mortality Rev Infect Dis 8 228-38
  • [2] Caballero-Salcedo A(1994)Seroepidemiology of amebiasis in Mexico Am J Trop Med Hyg 50 412-419
  • [3] Viveros-Rogel M(1988)Inflammatory reaction in experimental hepatic amebiasis. An ultrastructural study Am J Pathol 130 112-119
  • [4] Salvatierra B(2003) does not produce monocyte locomotion inhibitory factor (MLIF) produced by Parasite Immunol 25 99-101
  • [5] Tapia-Conyer R(1980)Efecto de Arch Invest Med 11 147-151
  • [6] Sepulveda-Amor J(1985) sobre la quimiotaxis de monocitos humanos Parasite Immunol 7 527-543
  • [7] Gutierrez G(1998)Inhibition of human monocyte locomotion by products of axenically grown Parasitol Res 84 522-523
  • [8] Tsutsumi V(1987)The monocyte locomotion inhibitory factor produced by Lab Invest 57 45-51
  • [9] Martínez-Palomo A(1991) does not inhibit the locomotion of human eosinophils Parasitol Res 77 374-378
  • [10] Silva García R(1992)Ultrastructural changes associated with the inhibition of monocyte chemotaxis caused by products of axenically grown Arch Med Res 23 157-159